GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSL:MEDI) » Definitions » Capex-to-Operating-Income

Medistim ASA (OSL:MEDI) Capex-to-Operating-Income : 0.00 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Medistim ASA's Capital Expenditure for the three months ended in Mar. 2024 was kr0.00 Mil. Its Operating Income for the three months ended in Mar. 2024 was kr32.07 Mil.

Hence, Medistim ASA's Capex-to-Operating-Income for the three months ended in Mar. 2024 was 0.00.


Medistim ASA Capex-to-Operating-Income Historical Data

The historical data trend for Medistim ASA's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA Capex-to-Operating-Income Chart

Medistim ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.11 0.10 0.15 0.23

Medistim ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medistim ASA's Capex-to-Operating-Income

For the Medical Devices subindustry, Medistim ASA's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Medistim ASA's Capex-to-Operating-Income falls into.



Medistim ASA Capex-to-Operating-Income Calculation

Medistim ASA's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-29.726) / 131.441
=0.23

Medistim ASA's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / 32.068
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medistim ASA  (OSL:MEDI) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Medistim ASA Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Medistim ASA's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Medistim ASA (OSL:MEDI) Business Description

Traded in Other Exchanges
Address
Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing and sales of medical equipment through its own business or through participation in other companies, as well related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, Asia and the Rest of the World. The firm's activity is split into three strategic operating units, Lease of equipment; Lease of equipment and Distribution and sales of third-party products.

Medistim ASA (OSL:MEDI) Headlines